Subbu Nambi
Stock Analyst at Guggenheim
(3.78)
# 775
Out of 4,761 analysts
26
Total ratings
50%
Success rate
12.24%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Buy | $170 → $150 | $94.20 | +59.24% | 2 | Feb 7, 2025 | |
| GH Guardant Health | Reiterates: Buy | n/a | $42.87 | - | 4 | Jan 22, 2025 | |
| BRKR Bruker | Reiterates: Buy | n/a | $50.82 | - | 2 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $170 → $200 | $162.31 | +23.22% | 2 | Jan 17, 2025 | |
| NEOG Neogen | Initiates: Buy | $15 | $10.04 | +49.40% | 1 | Dec 19, 2024 | |
| TEM Tempus AI | Initiates: Buy | $74 | $68.09 | +8.68% | 1 | Dec 9, 2024 | |
| GRAL GRAIL | Initiates: Neutral | n/a | $40.73 | - | 1 | Oct 17, 2024 | |
| VCYT Veracyte | Initiates: Buy | $40 | $39.18 | +2.09% | 1 | Oct 10, 2024 | |
| SOPH SOPHiA GENETICS | Initiates: Buy | $6 | $4.07 | +47.42% | 1 | Jun 27, 2024 | |
| NAUT Nautilus Biotechnology | Initiates: Buy | $6 | $1.54 | +289.61% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.90 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $158.99 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $53 | $41.31 | +28.30% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $25.75 | -2.91% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $14.18 | +62.20% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $49.26 | +82.70% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.54 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $2.05 | - | 1 | Dec 14, 2023 |
Illumina
Feb 7, 2025
Maintains: Buy
Price Target: $170 → $150
Current: $94.20
Upside: +59.24%
Guardant Health
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $42.87
Upside: -
Bruker
Jan 17, 2025
Reiterates: Buy
Price Target: n/a
Current: $50.82
Upside: -
Natera
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $162.31
Upside: +23.22%
Neogen
Dec 19, 2024
Initiates: Buy
Price Target: $15
Current: $10.04
Upside: +49.40%
Tempus AI
Dec 9, 2024
Initiates: Buy
Price Target: $74
Current: $68.09
Upside: +8.68%
GRAIL
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $40.73
Upside: -
Veracyte
Oct 10, 2024
Initiates: Buy
Price Target: $40
Current: $39.18
Upside: +2.09%
SOPHiA GENETICS
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.07
Upside: +47.42%
Nautilus Biotechnology
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $1.54
Upside: +289.61%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $10.90
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $158.99
Upside: -
Jun 5, 2024
Initiates: Buy
Price Target: $53
Current: $41.31
Upside: +28.30%
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $25.75
Upside: -2.91%
Dec 14, 2023
Initiates: Buy
Price Target: $23
Current: $14.18
Upside: +62.20%
Dec 14, 2023
Initiates: Buy
Price Target: $90
Current: $49.26
Upside: +82.70%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.05
Upside: -